1. Home
  2. FCCO vs TENX Comparison

FCCO vs TENX Comparison

Compare FCCO & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Community Corporation

FCCO

First Community Corporation

HOLD

Current Price

$30.07

Market Cap

290.5M

Sector

Finance

ML Signal

HOLD

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$11.87

Market Cap

317.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCCO
TENX
Founded
1994
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
290.5M
317.8M
IPO Year
2012
2001

Fundamental Metrics

Financial Performance
Metric
FCCO
TENX
Price
$30.07
$11.87
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$29.67
AVG Volume (30 Days)
61.4K
545.5K
Earning Date
04-22-2026
05-15-2026
Dividend Yield
2.16%
N/A
EPS Growth
36.46
N/A
EPS
0.59
N/A
Revenue
$922,000.00
N/A
Revenue This Year
$30.67
N/A
Revenue Next Year
$5.87
N/A
P/E Ratio
$51.02
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.80
$5.34
52 Week High
$31.51
$18.38

Technical Indicators

Market Signals
Indicator
FCCO
TENX
Relative Strength Index (RSI) 52.26 43.07
Support Level $29.16 $10.87
Resistance Level $31.21 $12.75
Average True Range (ATR) 0.67 0.67
MACD 0.03 0.06
Stochastic Oscillator 56.64 51.11

Price Performance

Historical Comparison
FCCO
TENX

About FCCO First Community Corporation

First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are: Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

Share on Social Networks: